Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10636 (
tau protein
)
5,110
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thyrotropin-releasing hormone
(
TRH
) is best known for its hypothalamic neuroendocrine role in regulating thyroid function. In extra-hypothalamic regions in vitro, we have shown
TRH
to have a protective effect against synaptic loss and neuronal apoptosis. A role for
TRH
in Alzheimer's disease (AD) has not been established previously. In this study, we examined the content of the
TRH
peptide in the hippocampus of elderly controls (n=5) and AD patients (n=7) by radioimmunoassay (RIA). The
TRH
concentration was decreased in the AD hippocampus compared to normal elderly controls (p < 0.01). In a separate series of experiments utilizing primary cell cultures made from rat hippocampus,
TRH
peptide concentration was depleted by the addition of
TRH
antiserum.
TRH
withdrawal was found to enhance the activity of glycogen synthetase kinase-3 (GSK-3beta), a critical enzyme necessary for the phosphorylation of tau, as well as the phosphorylation of the
tau protein
itself. This
TRH
depletion induced upregulation in phosphorylation that was observed to initiate axonal retraction in cultured neurons. These data suggest that
TRH
within the hippocampus can regulate the activity of various proteins by phosphorylation/dephosphorylation that may be involved in the pathogenesis of AD.
...
PMID:Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients. 1221 33